Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Systems Approach to Neurodegenerative Disease Biomarker Discovery

25 Oct 2013

Abstract excerpt

Biomarkers are essential for performing early diagnosis, monitoring neurodegenerative disease progression, gauging responses to therapies, and stratifying neurodegenerative diseases into their different subtypes. A wide range of molecular markers are under investigation in tissues and biofluids as well as through imaging; moreover, many are prominent proteins present in cerebrospinal fluid. However, in more...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Proteomics Techniques and Applications
Share to Alzheimer's disease research and treatments
Share to Metabolomics and Mass Spectrometry Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24160693
DOI: 10.1146/annurev-pharmtox-011613-135928

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Systems Approach to Neurodegenerative Disease Biomarker DiscoveryPMID 24160693Read ↗

Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology.Semantic proximity Read ↗

Biomarker Discovery in Alzheimer’s and Neurodegenerative Diseases using Nucleic Acid-Linked Immuno-Sandwich AssaySemantic proximity Read ↗

Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseasesSemantic proximity Read ↗

Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosisSemantic proximity Read ↗

Genetic and Transcriptomic Biomarkers in Neurodegenerative Diseases: Current Situation and the Road Ahead.Semantic proximity Read ↗

The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseasesSemantic proximity Read ↗

Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomicsSemantic proximity Read ↗

Changes in the cerebrospinal fluid proteome precede and stratify the course of Parkinson’s DiseaseSemantic proximity Read ↗

The Need for Biomarkers in the ALS–FTD Spectrum: A Clinical Point of View on the Role of ProteomicsSemantic proximity Read ↗

Data-driven biomarker analysis using computational omics approaches to assess neurodegenerative disease progressionSemantic proximity Read ↗

Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer’s diseaseSemantic proximity Read ↗

The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and agingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.